theinvestor22 wrote: Given the fact that they (more or less) took previously stated Q3 revenue and moved it into y-e bad debt expense, I can't see the need to restate Q3, especially if they thought they could collect Q3 revenue at the time (way back at the end of March).
Since accounts receivable at year-end is very small, I'm concluding that they not only collected the $592k they mentioned in the Q3 cc, but also almost all of the rest of Q2's $878k revenue. That's a good thing.
Also, at first blush, Q4 cash flow looks bad, but after adjusting for the $2+M deposit to ForaCare, this isn't as bad as I thought. Nonetheless, expenses were a bit higher than I would've liked. Overall, not the end of the world.
Here's a quote from the financials regarding the Texas lawsuit:
"The Company is aware of a claim brought in the Northern District of Texas against the Company for breach of contract. As at the date of these consolidated financial statements, the Company is contesting the jurisdiction of the court proceedings and has not filed a defense to the claim. The company cannot access the possible outcome from this claim but is of the opinion that this claim is of no merit."
I'm quite looking forward to the conference call/webinar.